Stereotaxis, Inc. Appoints Dr. Gery Tomassoni M.D. FHRS Chief Medical Officer
Published: Aug 07, 2012
ST. LOUIS, Aug. 6, 2012 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that Gery Tomassoni M.D. FHRS has been appointed as Chief Medical Officer (CMO), effective immediately for a three-year term. Dr. Tomassoni is Director of Electrophysiology at Central Baptist Hospital in Lexington, KY. In this capacity, Dr Tomassoni will serve as the Company's clinical leader for scientific, product, clinical training and applications development. He will continue his practice in Lexington, KY and consult in his new role on a part time basis.